Professor Richard Scolyer
Professor Richard Scolyer is Co-Medical Director and Consultant Pathologist at Melanoma Institute Australia; Senior Staff Specialist, Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney; and Clinical Professor, The University of Sydney.
Professor Scolyer studied medicine at the University of Tasmania. After completing clinical training in Australia and overseas, he undertook pathology training at the Canberra Hospital and at the Royal Prince Alfred Hospital leading to Fellowship of the Royal College of Pathologists of Australasia. He provides a clinical consultation service for the diagnosis of difficult pigmented lesions and receives more 2000 cases for opinion from Australasia and beyond annually.
Professor Scolyer effectively integrates his clinical practice with leading an award-winning translational melanoma research laboratory. His record includes co-authoring more than 500 publications including in prestigious journals such as the New England Journal of Medicine, Lancet, Nature, Cell, Nature Genetics, Lancet Oncology, Journal of Clinical Oncology, Journal of the National Cancer Institute and Cancer Discovery. Richard has presented on more than 300 occasions at conferences throughout the world.
In 2006, Professor Scolyer was awarded the degree of Doctor of Medicine by The University of Sydney for his thesis of publications on melanocytic pathology. He received NSW Premier's Awards for Outstanding Cancer Research in 2009, 2012, 2013, 2014, 2016, 2017 and 2018, the Thomson Reuters 2015 Citation Award in the Clinical Medicine category, 2018 William O. Russell/Joanne Vandenberge Hill Award for Lifetime Achievement in Anatomical Pathology, MD Anderson Cancer Center and the Research Australia’s 2018 GSK Award for Research Excellence. . His publications have received most highly cited awards on five other occasions. According to Thomson Reuters ISI Web of Knowledge, Professor Scolyer is the highest published scientist in the world in the field of melanoma pathology and he also has the highest H index in this field. The Fame Report (2011) published by Medical Experts International ranked him the 6th leading melanoma expert in any field or discipline worldwide and the highest ranked melanoma pathologist worldwide. In February 2018, he was ranked the world’s 10th leading melanoma expert in any field or discipline and the world’s leading melanoma pathologist.
Professor Scolyer is editor of the 4th Edition of the World Health Organisation Classification of Tumours Skin Tumours volume in which he was the responsible editor for 3 of the 6 sections and authored/co-authored more than 30 chapters. He is also Vice Chair of the Melanoma Expert Panel of the American Joint Committee on Cancer (AJCC) for the 8th edition of AJCC Cancer Staging System, co-leads the Australian Melanoma Genome Project (part of the International Cancer Genome Consortium) (published in Nature 2017), was lead pathologist for the NIH funded The Cancer Genome Atlas (TCGA) Melanoma Project (published inCell), chairs the Melanoma Expert Panel for the International Collaboration on Cancer Reporting, and lead pathologist/member of the overseeing Management Committee, Multidisciplinary Working Party and Author for the Australian Melanoma Clinical Practice Guidelines and primary author of the College of American Pathologists Melanoma Reporting protocol. He is also an editorial board member of the American Journal of Surgical Pathology, a member of the International Editorial Advisory Board of Histopathology and Senior Associate Editor of Pathology and a number of other international journals. Professor Scolyer is Immediate Past President of the Australasian Division of the International Academy of Pathology. Together with other MIA colleagues, he is chief investigator on a 5-year NHMRC program grant and has a personal Fellowship from the NHMRC.